Skip to content
Open access · CC-BY via OpenAlex

Proteomics efforts for hepatocellular carcinoma drug development

Dongling Jia, Zongtai Jiang, Minhui Cui, Xianting Ding

Clinical Cancer Bulletin · 2024 · ▲ 7 citations

Abstract

Abstract Hepatocellular carcinoma (HCC) is a malignant tumor associated with high global incidence and mortality rates. Proteomics, as a platform technology of cellular protein expression, modification, and interaction, has provided innovative perspectives on early diagnosis, treatment, and targeted drug development for HCC. This review summarizes recent progress in proteomics for advancing HCC biomarker discovery, drug target identification, and understanding drug action mechanisms. Proteomic technologies, including mass spectrometry for specific protein signatures identification, protein microarrays for high-throughput analysis, and bioinformatics for data interpretation, have profoundly promoted the identification of liver cancer-specific biomarkers. These advancements not only facilitate early diagnosis but also improve prognostic assessment. Proteomics is pivotal in expediting the discovery and development of new drugs, providing more effective and personalized treatment options for HCC patients. This review offers a comprehensive overview of the applications of proteomics in anti-HCC drug research, serving as a reference to further advance the development of HCC research and treatment domains.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1007/s44272-024-00027-7
Canonical
link ↗
Fetched
2026-11-04 MST

Cite this

APA
Jia, D., Jiang, Z., Cui, M., &amp; Ding, X. (2024). Proteomics efforts for hepatocellular carcinoma drug development. <em>Clinical Cancer Bulletin</em>. https://doi.org/10.1007/s44272-024-00027-7
Vancouver
Jia D, Jiang Z, Cui M, Ding X. Proteomics efforts for hepatocellular carcinoma drug development. Clinical Cancer Bulletin. 2024. doi:10.1007/s44272-024-00027-7.
BibTeX
@article{dongling2024Proteo, title = {Proteomics efforts for hepatocellular carcinoma drug development}, author = {Dongling Jia and Zongtai Jiang and Minhui Cui and Xianting Ding}, journal = {Clinical Cancer Bulletin}, year = {2024}, doi = {10.1007/s44272-024-00027-7}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings